A
$ Value
$0
Shares
75,000
Price
$0
Filed
Jul 3
Insider
Name
Bradsher Neal C
Title
—
CIK
0001278388
Roles
Director
10% Owner
Transaction Details
Transaction Date
2025-07-01
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
75,000
Footnotes
These options will vest and become exercisable on the earlier of: (a) July 1, 2026 and (b) the date of Lineage Cell Therapeutics, Inc.'s (the "Issuer") next annual meeting of shareholders after the grant date, subject, in each case, to Neal C. Bradsher's (the "Reporting Person") continuous service with the Issuer. | These options were granted to the Reporting Person by the Issuer on July 1, 2025 as director compensation pursuant to the Issuer's 2021 Equity Incentive Plan, as amended. | These options are currently exercisable.
Filing Info
Other Insiders at LCTX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Culley Brian M
President and CEO
|
$24K | — | 2026-03-12 |
|
Samuel George A. III
General Counsel and Secretary
|
— | — | 2026-03-05 |
|
Howe Jill Ann
Chief Financial Officer
|
— | — | 2026-03-05 |